Biocompatibility test procedures for materials evaluation in vitro. II. Objective methods of toxicity assessment.
Methods of assessing the biocompatibility of materials for use in medical devices were evaluated. Ten materials were tested using quantitative, objectively graded in vitro biochemical and functional assays employing four cell lines (CCL 1, 74, 76, and 131) used in previous work and five primary cell types (human lymphocytes, polymorphonuclear leukocytes, and mixed leukocytes, mouse macrophages, and mouse embryo). The biochemical methods (DNA synthesis, protein synthesis, and ATP activity) demonstrated good agreement in toxicity ranking of the materials, regardless of which cell culture was used and, also, the cell cultures responded similarly for each method. Methods that measured functional characteristics of cells (adhesion and phagocytosis) were highly sensitive but had low toxicity ranking agreement and reproducibility. Assays (defined as method and cell culture combinations) using cell lines were more reproducible than assays using primary cell types. Significant differences in sensitivity were noted among the assay systems for particular material types. The in vitro assays were more sensitive to differences in material composition than was a 90-day assay by subcutaneous implantation in rats.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001672:Biocompatible Materials / Q000633:toxicity*; D002448:Cell Adhesion / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D010587:Phagocytosis / Q000187:drug effects; D019736:Prostheses and Implants / Q000009:adverse effects; D014176:Protein Biosynthesis; D051381:Rats
D001672:Biocompatible Materials; D000255:Adenosine Triphosphate; D004247:DNA